Shaping the Future of AI Medical Devices:
A Symposium on the Regulation of AI in Health Care and its Policy Implications
April 18, 2024
Johns Hopkins Bloomberg Center
Theater
555 Pennsylvania Avenue, NW
Washington, D.C.
Artificial intelligence is making significant strides in the healthcare industry, with AI-enhanced medical devices playing an increasingly important role in diagnosis, treatment, and patient care. With more than 690 FDA-approved AI medical devices available, the use of AI in healthcare presents unique regulatory challenges that require careful consideration. This symposium, co-hosted by the Johns Hopkins Carey Business School and Johns Hopkins School of Medicine, will explore lessons from this relatively short regulatory history, what remains to be understood from a regulatory science perspective, challenges in the use of AI in clinical care, and implications for future innovation and policymaking.
This symposium is by invitation only. For questions, contact Professor Phillip Phan.
Get more information on parking and transportation around the Johns Hopkins Bloomberg Center by clicking on these links:
Agenda
Time
Agenda Item
8 a.m.
Registration and breakfast
9 a.m.
Welcome
9:30 a.m.
KEYNOTE ADDRESS
Aldo Badano
Director, Division of Imaging, Diagnostics, and Software Reliability, and Center for Device and Radiological Health, Food and Drug Administration
Regulation and Policy Roundtable
Nicholson Price (Moderator)
Professor, University of Michigan School of Law
Jana Delfino
Deputy Director, Division of Imaging, Diagnostics, and Software Reliability, Food and Drug Administration
Jennifer Kuskowski
Vice President, Government Affairs, Siemens Healthineers
Pat Baird
Head Global Software Standards, Philips
11 a.m.
Coffee break
11:15 a.m.
KEYNOTE ADDRESS
Christopher Khoury
Vice President, American Medical Association
Clinical Practice Roundtable
Julian Goldman
Professor, Mass General Brigham (Moderator)
Michael Spaeder
Professor, University of Virginia Medical Center
Jeremy Walston
Professor, Johns Hopkins Medicine
Robert Ochs
Director, Office of Health Technology 8, Food and Drug Administration
12:45 p.m.
Lunch and networking
2:25 p.m.
KEYNOTE ADDRESS
Peter Shen
Head of Digital and Automation, Siemens Healthineers
Industry and innovation (proposed)
Venk Varadan (Moderator)
Co-founder/CEO, Nanowear
Therese Canares
Founder/CEO, CurieDx
Anand Iyer
Chief Technology Officer, Welldoc Inc.
Peter Weems
Vice President, Imaging Government Affairs, Advamed
3:45 p.m
Closing
4:15 p.m.
Cocktail reception